Biology and Treatment of Paget's Disease of Bone

J Cell Biochem. 2016 Feb;117(2):289-99. doi: 10.1002/jcb.25291. Epub 2015 Sep 3.

Abstract

Paget's disease of bone (PDB) is a common skeletal disorder characterized by increased and disorganized bone remodeling affecting one or more skeletal sites. Although some patients are asymptomatic others develop complications such as bone pain, deformity, nerve compression syndromes, and fragility fractures. Genetic factors play an important role in the pathogenesis of PDB and there is strong evidence that susceptibility is determined by variants within or close to genes that regulate osteoclast function. Environmental factors also play a key role but the nature of the environmental triggers is less clear. Bisphosphonates are a highly effective treatment for the elevations in bone turnover that are characteristic of PDB but it is unclear at present if they alter the natural history of the disease. Here, we review the epidemiology, clinical, cellular, and molecular abnormalities in PDB as well as environmental and genetic triggers, and current available treatment options.

Keywords: BISPHOSPHONATES; BONE DISEASE; PAGET'S DISEASE.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Remodeling
  • Humans
  • Mutation
  • Osteitis Deformans / epidemiology
  • Osteitis Deformans / etiology
  • Osteitis Deformans / pathology*
  • Osteitis Deformans / therapy